Two doses of intrathecal sufentanil (2.5 and 5 microg) combined with bupivacaine and epinephrine for labor analgesia
- PMID: 10553847
Two doses of intrathecal sufentanil (2.5 and 5 microg) combined with bupivacaine and epinephrine for labor analgesia
Abstract
In this study, we evaluated the effect of two doses of intrathecal sufentanil combined with bupivacaine and epinephrine on the incidence of pruritus and on the duration and quality of analgesia. One hundred five parturients were enrolled in this randomized, double-blinded, placebo-controlled study. They received either intrathecal 1.25 mg bupivacaine and 25 microg epinephrine (control group); 1.25 mg bupivacaine, 25 microg epinephrine, and 2.5 microg sufentanil (2.5-microg group); or 1.25 mg bupivacaine, 25 microg epinephrine, and 5 microg (5-microg group). Pain relief was assessed 10 min after injection, and pruritus was recorded at 30 min by a blinded observer. The study ended when the parturients requested further analgesia. There were no demographic differences among groups. Ninety of 103 parturients achieved complete pain relief with the initial dose, 11 patients in the control group (P < 0.004, control versus both sufentanil groups), and 2 patients in the 2.5-microg group needed a supplemental epidural bupivacaine. Pruritus was absent in the control group (P < 0.0001, control versus both sufentanil groups), whereas it was present in 36% of the 2.5-microg group and in 66% of the 5-microg group (P = 0.015, 2.5-microg versus 5-microg group). The mean duration of analgesia was similar in patients receiving sufentanil (2.5-microg group: 133 +/- 55 min; 5-microg group: 142 +/- 52 min) but was significantly higher than the control group (56 +/- 32 min). Reducing the sufentanil dose from 5 microg to 2.5 microg when combined with bupivacaine and epinephrine, decreases the incidence of pruritus without impeding the quality or duration of analgesia.
Implications: We evaluated two different doses of intrathecal sufentanil combined with bupivacaine and epinephrine for labor analgesia. Sufentanil 2.5 microg offered an advantage over sufentanil 5 microg because, while providing the same quality and duration of analgesia, it was associated with a reduced incidence of pruritus.
Similar articles
-
Intrathecal sufentanil versus epidural lidocaine with epinephrine and sufentanil for early labor analgesia.Anesth Analg. 1998 Aug;87(2):331-5. doi: 10.1097/00000539-199808000-00018. Anesth Analg. 1998. PMID: 9706926 Clinical Trial.
-
Intrathecal sufentanil and fetal heart rate abnormalities: a double-blind, double placebo-controlled trial comparing two forms of combined spinal epidural analgesia with epidural analgesia in labor.Anesth Analg. 2004 Apr;98(4):1153-1159. doi: 10.1213/01.ANE.0000101980.34587.66. Anesth Analg. 2004. PMID: 15041616 Clinical Trial.
-
Spinal analgesia during labor with low-dose bupivacaine, sufentanil, and epinephrine. A comparison with epidural analgesia.Reg Anesth. 1996 May-Jun;21(3):191-6. Reg Anesth. 1996. PMID: 8744659 Clinical Trial.
-
Sufentanil versus fentanyl for pain relief in labor involving combined spinal-epidural analgesia: a systematic review and meta-analysis of randomized controlled trials.Eur J Clin Pharmacol. 2020 Apr;76(4):501-506. doi: 10.1007/s00228-019-02806-x. Epub 2020 Jan 7. Eur J Clin Pharmacol. 2020. PMID: 31912188
-
Sufentanil: clinical use as postoperative analgesic--epidural/intrathecal route.J Pain Symptom Manage. 1992 Jul;7(5):271-86. doi: 10.1016/0885-3924(92)90061-l. J Pain Symptom Manage. 1992. PMID: 1352535 Review.
Cited by
-
Intrathecal opioids for combined spinal-epidural analgesia during labour.CNS Drugs. 2003;17(12):889-904. doi: 10.2165/00023210-200317120-00003. CNS Drugs. 2003. PMID: 12962528 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources